The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Infinity Pharmaceuticals Inc

Nasdaq: INFI
Last

(U.S.) $2.08

Today's change+0.08 +4.00%
Updated January 23 4:00 PM EST. Delayed by at least 15 minutes.
 

Infinity Pharmaceuticals Inc

Nasdaq: INFI
Last

(U.S.) $2.08

Today's change+0.08 +4.00%
Updated January 23 4:00 PM EST. Delayed by at least 15 minutes.

Infinity Pharmaceuticals Inc Hits New 100-day High

Infinity Pharmaceuticals Inc closed up sharply Monday, rallying (U.S.)$0.08 or 4.00% to (U.S.)$2.08 and setting a new 100-day high. Over the last five days, shares have gained 38.67%, but are down 68.34% for the last 52 weeks, lagging the 18.79% return in the S&P 500.

Key company metrics

  • Open(U.S.) $1.97
  • Previous close(U.S.) $2.00
  • High(U.S.) $2.36
  • Low(U.S.) $1.91
  • Bid / Ask(U.S.) $1.95 / (U.S.) $2.07
  • YTD % change+54.07%
  • Volume7,303,566
  • Average volume (10-day)1,654,802
  • Average volume (1-month)1,019,899
  • Average volume (3-month)689,778
  • 52-week range(U.S.) $0.84 to (U.S.) $7.07
  • Beta2.52
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.94
Updated January 23 4:00 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue0999
Total other revenue--------
Total revenue0999
Gross profit--------
Total cost of revenue--------
Total operating expense20-445048
Selling / general / administrative716119
Research & development13533939
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-2053-41-39
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax-1953-41-39
Income after tax-1953-41-39
Income tax, total0----0
Net income-1953-41-39
Total adjustments to net income--------
Net income before extra. items-1953-41-39
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1953-41-39
Inc. avail. to common incl. extra. items-1953-41-39
Diluted net income-1953-41-39
Dilution adjustment--0----
Diluted weighted average shares50494949
Diluted EPS excluding extraordinary itemsvalue per share-0.391.07-0.82-0.80
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.391.07-0.82-0.80